A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone.

Autor: Ho Won Kang1, Hee Youn Lee1, Young Joon Byun1, Pildu Jeong1, Jin Sun Yoon2, Dong Ho Kim2, Won Tae Kim1, Yong-June Kim1, Sang-Cheol Lee1, Seok Joong Yun1 sjyun@chungbuk.ac.kr, Wun-Jae Kim1
Zdroj: Investigative & Clinical Urology. Jul2020, Vol. 61 Issue 4, p411-418. 8p.
Databáze: Academic Search Ultimate